Dr. Sarah Ahmad Safadi, MD

Dr. Safadi practices at Uchealth Ccmc Infusion Outpatient - Chemotherapy - HOPD in Denver, Colorado.

Dr. Safadi's NPI, 1992117675, was assigned on May 29, 2014. Dr. Safadi graduated from Jordan University of Science and Technology FOM in 2012. Dr. Safadi holds Colorado license DR.0066192.

Dr. Safadi's primary practice is Uchealth Ccmc Infusion Outpatient - Chemotherapy - HOPD, at 100 Cook St, Denver, CO 80206.

Dr. Safadi's primary practice is Uchealth Ccmc Infusion Outpatient - Chemotherapy - HOPD in Denver, Colorado. Dr. Safadi is also affiliated with UCHealth University of Colorado Hospital. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Safadi to 2 more hospitals, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Safadi practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Safadi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Safadi is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Safadi's licenses on file in 3 states: Colorado, Kentucky and New Mexico.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis, gastrointestinal bleeding, intestinal diverticulosis, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Safadi treats.

CMS data shows 97 Medicare services from Dr. Safadi across 4 procedure codes in 2024, for 111 Medicare patients. Medicare paid $12,810 for them.

CMS counts 111 Medicare patients who saw Dr. Safadi in 2024. The largest group is 65 to 74, with 54 patients. 73% of them have high cholesterol, and 58% have arthritis. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Safadi's median patient age at 53, with 57% women.

In 2024, Dr. Safadi wrote 352 Medicare Part D claims for 168 patients. 73% of them were for generic drugs. CMS names the drug for 233 of them, across 7 drugs with 11 or more claims each, at $44,704 in total drug cost.

Dr. Safadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Safadi as offering telehealth. CMS counts 99 procedures of colonoscopy by Dr. Safadi, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Safadi, published from 2016 to 2020. Dr. Safadi has published most often in Dig Dis Sci. Dr. Safadi's most frequent co-authors are Ursa Abigail Brown-Glaberman, MD, Adam Nicol Delu, MD and Shadi Mayasy, MD.

CMS Open Payments shows 3 general payments to Dr. Safadi from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Madrigal Pharmaceuticals paid the most, $57.

Dr. Safadi graduated from Jordan University of Science and Technology FOM in 2012.

Dr. Safadi is in network with 17 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.